Accident at Sainor unit in Vizag more proof of companies bypassing rules
Life-saving equipments were absent on-site though the company had approvals to show they were present
Marxists vs Paternalists vs Liberals: Where healthcare stands in India
How health as a right, investment and consumption regularly crops up in capitalist discourses
More give than take in secret trade deals
The tight secrecy over trade negotiations means citizens are not privy to the deals that affect them directly
Pharma is getting high on marijuana
As drug companies develop cannabis-based medicines for serious illnesses, generic firms are trying to get into the act
The right pill
Africa will be setting up its first agency to check the spread of spurious drugs
COVID-19 exposes India’s dependence on China for active pharma ingredients
India imports around 90 per cent of APIs used to make antibiotics, says an expert
Second guilty verdict against Monsanto in the US
Federal jury finds that Monsanto’s Roundup herbicide caused a man’s cancer
Centre fails to weed out substandard drugs, reign in prices: Parl panel
It recommends that the government adopt cost of production-based pricing system
COVID-19 also brings focus back on pollution due to pharmaceuticals
No time for quick-fix measures. India needs stricter laws
COVID-19: Centre brings package to boost bulk drugs
Indian pharma industry is critically dependent on imported raw material
Suspect claims in Teva’s suit against Cipla
The US Federal Trade Commission has warned the Israeli drug firm its patents are wrongful as it sues Cipla aggressively